E Fund Management Co. Ltd. Makes New Investment in HCA Healthcare, Inc. $HCA

Posted by Stanley Muller on Aug 21st, 2026

E Fund Management Co. Ltd. acquired a new stake in HCA Healthcare, Inc. (NYSE:HCA – Free Report) during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm acquired 1,343 shares of the company’s stock, valued at approximately $524,000.

Other hedge funds and other institutional investors also recently bought and sold shares of the company. BlackRock Inc. purchased a new position in shares of HCA Healthcare in the 2nd quarter valued at about $5,069,974,000. Norges Bank acquired a new position in HCA Healthcare in the fourth quarter valued at approximately $1,262,513,000. Life Cycle Investment Partners Ltd acquired a new stake in HCA Healthcare during the fourth quarter worth approximately $374,037,000. Viking Global Investors LP grew its position in shares of HCA Healthcare by 58.5% in the 2nd quarter. Viking Global Investors LP now owns 1,872,133 shares of the company’s stock valued at $717,214,000 after buying an additional 690,773 shares during the last quarter. Finally, Northwestern Mutual Wealth Management Co. lifted its position in HCA Healthcare by 4,545.5% in the fourth quarter. Northwestern Mutual Wealth Management Co. now owns 663,337 shares of the company’s stock valued at $309,686,000 after acquiring an additional 649,058 shares during the last quarter. 62.73% of the stock is currently owned by institutional investors and hedge funds.

HCA Healthcare Trading Down 0.2%

NYSE:HCA opened at $406.33 on Friday. The stock’s 50 day simple moving average is $396.32 and its 200-day simple moving average is $444.25. HCA Healthcare, Inc. has a 12-month low of $353.99 and a 12-month high of $556.52. The firm has a market cap of $87.97 billion, a P/E ratio of 13.60, a PEG ratio of 1.41 and a beta of 1.10.

HCA Healthcare (NYSE:HCA – Get Free Report) last posted its quarterly earnings data on Friday, July 24th. The company reported $7.59 earnings per share for the quarter, beating analysts’ consensus estimates of $7.56 by $0.03. HCA Healthcare had a net margin of 8.77% and a negative return on equity of 244.79%. The firm had revenue of $20.23 billion for the quarter, compared to analyst estimates of $19.76 billion. During the same period last year, the firm posted $6.84 EPS. HCA Healthcare’s quarterly revenue was up 8.7% on a year-over-year basis. Research analysts forecast that HCA Healthcare, Inc. will post 29.47 EPS for the current fiscal year.

HCA Healthcare Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, September 30th. Investors of record on Wednesday, September 16th will be given a $0.78 dividend. The ex-dividend date is Wednesday, September 16th. This represents a $3.12 dividend on an annualized basis and a yield of 0.8%. HCA Healthcare’s dividend payout ratio (DPR) is presently 10.45%.

Wall Street Analyst Weigh In

A number of analysts have recently commented on the company. Wall Street Zen cut HCA Healthcare from a “buy” rating to a “hold” rating in a research report on Saturday, May 2nd. The Goldman Sachs Group cut their price target on HCA Healthcare from $558.00 to $485.00 and set a “buy” rating on the stock in a research report on Tuesday, July 28th. Mizuho lowered their target price on shares of HCA Healthcare from $525.00 to $475.00 and set an “outperform” rating on the stock in a research report on Tuesday, July 28th. Sanford C. Bernstein reiterated a “market perform” rating on shares of HCA Healthcare in a research report on Wednesday, July 15th. Finally, Leerink Partners dropped their price objective on shares of HCA Healthcare from $573.00 to $500.00 and set an “outperform” rating on the stock in a research note on Monday, April 27th. Fourteen analysts have rated the stock with a Buy rating, eight have issued a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average target price of $462.64.

Get Our Latest Stock Report on HCA

HCA Healthcare Profile

(Free Report)

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.